The Pennant Group, Inc. (PNTG) Q4 2025 Earnings Call Transcript

The Pennant Group, Inc. (PNTG) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 26, 2026

The Pennant Group (PNTG) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for The Pennant Group (PNTG) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Feb 26, 2026

Pennant Reports Fourth Quarter and Fiscal Year 2025 Results

EAGLE, Idaho, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.84 for the full year and $0.24 for the fourth quarter of 2025. Pennant also reported adjusted diluted earnings per share of $1.18 for the full year and $0.34 for the quarter(1 ).

GlobeNewsWire • Feb 25, 2026

The Pennant Group, Inc. (PNTG) Earnings Expected to Grow: Should You Buy?

The Pennant Group (PNTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Feb 18, 2026

Pennant Announces Fourth Quarter and Year-End 2025 Earnings Release and Call

EAGLE, Idaho, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its fourth quarter and fiscal year 2025 financial results on Wednesday, February 25, 2026. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Thursday, February 26, 2026, at 10:00 a.m.

GlobeNewsWire • Feb 12, 2026

4 Outpatient Home Health Stocks in Focus as Market Dynamics Change

An aging population and rising AI adoption position the Zacks Medical - Outpatient and Home Healthcare industry for solid growth. EHC, DVA, OPCH and PNTG stand to benefit.

Zacks Investment Research • Dec 19, 2025

The Pennant Group, Inc. (PNTG) Just Flashed Golden Cross Signal: Do You Buy?

The Pennant Group, Inc. (PNTG) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PNTG's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

Zacks Investment Research • Dec 8, 2025

Does The Pennant Group (PNTG) Have the Potential to Rally 30.69% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in The Pennant Group (PNTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research • Nov 13, 2025

The Pennant Group, Inc. (PNTG) Q3 2025 Earnings Call Transcript

The Pennant Group, Inc. ( PNTG ) Q3 2025 Earnings Call November 6, 2025 12:00 PM EST Company Participants Kirk Cheney - Executive VP, General Counsel & Corporate Secretary Brent Guerisoli - CEO & Chairman John Gochnour - President & COO Lynette Walbom - Chief Financial Officer Conference Call Participants David MacDonald - Truist Securities, Inc., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to The Pennant Group Third Quarter 2025 Earnings Call.

Seeking Alpha • Nov 6, 2025

The Pennant Group, Inc. (PNTG) Tops Q3 Earnings and Revenue Estimates

The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.26 per share a year ago.

Zacks Investment Research • Nov 6, 2025